Fluoroscopy in Massachusetts

Xingaoyi Medical Equipment Co., Ltd. is a National High-Tech enterprise headquartered in Yuyao City, Zhejiang Province, China. The company specializes in the design, manufacture, and distribution of advanced medical diagnostic and imaging equipment. Annual production capacity includes 200 units of Magnetic Resonance Imaging (MRI) systems (both superconductive and permanent magnet types), 100 units of Digital Radiography (DR) systems, and 50 units of Digital Radiology Fluoroscopy (DRF) systems. The company operates a provincial-level MRI research and development center, an enterprise postdoctoral workstation, and an academician workstation. Xingaoyi has undertaken high-tech industrialization projects for medical MRI systems under the National Development and Reform Commission (NDRC), the Torch Plan of the Ministry of Science and Technology, and National Science and Technology support initiatives. Product portfolio includes superconductive and permanent magnet MRI systems; suspended, pillar-mounted, and bone density measurement X-ray systems; integrated operating room solutions; and Magnetic Wave Knife technology. The company provides comprehensive support including technical assistance, market support, telemedicine capabilities, and equipment servicing with a commitment to 45-day contract completion. Distribution and service infrastructure extends globally, targeting county hospitals, regional medical centers, and healthcare systems seeking cost-effective diagnostic solutions.

Body Vision Medical is a commercial-stage medical device company specializing in AI-powered imaging solutions for lung cancer detection and intervention. The company's flagship product, the LungVision® system, transforms standard 2D C-arm X-ray images into advanced 3D intraoperative imaging for enhanced navigation during endobronchial biopsies. Utilizing proprietary AI Tomo® technology, LungVision corrects for CT-to-body divergence and enables tool-in-lesion confirmation, improving diagnostic yield from traditional 55-75% to approximately 90-95% for small pulmonary lesions. The system delivers superior economics with lower total cost of ownership than robotic alternatives, reduced radiation exposure (1/5 of 3D C-arms), and accessibility worldwide. Founded in 2014 by engineers experienced in electromagnetic navigation bronchoscopy, Body Vision empowers pulmonologists and thoracic surgeons with real-time, high-precision navigation for biopsy and localized therapy delivery. Recognized as a Top Medtech Startup in 2023.